Prelude Capital Management’s Zepp Health ZEPP Stock Holding History

Prelude Capital Management’s Portfolio ZEPP Stock Details ZEPP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,506	Closed	-$283K	–	2084
2020 Q3	$283K	Buy	+5,506	New	+$302K	0.01%	580
2018 Q3	–	Sell	-588	Closed	-$23K	–	2086
2018 Q2	$23K	Buy	+588	New	+$24.2K	﹤0.01%	1328

Other funds holding ZEPP

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Prelude Capital Management's ZEPP Position: Q4 2020 in Review

Prelude Capital Management sold out of Zepp Health (ZEPP) in Q4 2020, closing a stake of 5,506 shares — an estimated $283K sold.

Prelude Capital Management first reported a position in ZEPP in Q2 2018 and held it in 2 quarters. The position peaked at $283K in Q3 2020. 56 funds tracked by Wall St. Rank hold ZEPP as of Q4 2020.

Prelude Capital Management reported no remaining Zepp Health position as of Q4 2020 after selling out during the quarter.
Prelude Capital Management sold 5,506 Zepp Health shares in Q4 2020, an estimated $283K.
Prelude Capital Management first reported a position in Zepp Health in Q2 2018 and held it in 2 quarters.
Prelude Capital Management's Zepp Health position peaked at $283K in Q3 2020.
56 funds tracked by Wall St. Rank held Zepp Health as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.